Hollow Gold Nanoparticles as Efficient In Vivo Radiosensitizing Agents for Radiation Therapy of Breast Cancer
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High-Z nanoplatforms based on silver, gadolinium, platinum, gold, and bismuth enhance radiation-induced energy deposition through photoelectric interactions and secondary electron generation.
“High-atomic-number (high-Z) nanoplatforms based on silver (Z = 47), gadolinium (Z = 64), platinum (Z = 78), gold (Z = 79), and bismuth (Z = 83) enhance radiation-induced energy deposition through photoelectric interactions and secondary electron generation [15,20,27,28,30,33,34,36,50,63].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone.
“Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone [17,20,39,40,43,50,63,80].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
While ROS amplification and DNA damage remain the most consistently reported foundational processes, nanoplatforms combining physical dose enhancement with biologically active components such as hypoxia-targeting systems, catalytic redox modulators, or immune-related approaches demonstrate more robust and sustained antitumor effects across preclinical models.
“While ROS amplification and DNA damage remain the most consistently reported foundational processes [15,20,30,33,63], nanoplatforms combining physical dose enhancement with biologically active components, such as hypoxia-targeting systems, catalytic redox modulators, or immune-related approaches, demonstrate more robust and sustained antitumor effects across preclinical models [17,19,21,26,39,45,”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
The earliest and most extensively investigated approach is conventional radiotherapy enhancement based on high-atomic-number nanomaterials, including gold, silver, platinum, bismuth, gadolinium, and hafnium-containing nanoparticles.
“The earliest and most extensively investigated approach is conventional radiotherapy enhancement based on high-atomic-number (high-Z) nanomaterials, including gold, silver, platinum, bismuth, gadolinium, and hafnium-containing nanoparticles [15,20,27,28,30,33,34,36,50,63].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
Detailed dosimetric characterization was frequently lacking, reducing reproducibility and limiting radiobiological interpretation.
“Radiation parameters were inconsistently reported, with considerable variability in total dose, fractionation schedules, beam energy, dose rate, and irradiation modality [15,20,24,30,52,63,74], while detailed dosimetric characterization was frequently lacking, reducing reproducibility and limiting radiobiological interpretation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
Radiation parameters were inconsistently reported, with considerable variability in total dose, fractionation schedules, beam energy, dose rate, and irradiation modality.
“Radiation parameters were inconsistently reported, with considerable variability in total dose, fractionation schedules, beam energy, dose rate, and irradiation modality [15,20,24,30,52,63,74], while detailed dosimetric characterization was frequently lacking, reducing reproducibility and limiting radiobiological interpretation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [63]
Cited by
Sorted by citations
Zhang, Y., Huang, F., Ren, C., Liu, J., Yang, L., Chen, S., Chang, J., Yang, C., Wang, W., Zhang, C., et al. (2019) · Advanced Science · doi:10.1002/advs.201801806 · Cited by 150 · see citing works
Yang, Q., Peng, J., Xiao, Y., Li, W., Tan, L., Xu, X., & Qian, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b14705 · Cited by 130 · see citing works
Wang, R., Deng, J., He, D., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.12.005 · Cited by 58 · see citing works
Metallic nanoparticle radiosensitization: The role of Monte Carlo simulations towards progress
Moradi, F., Saraee, K. R. E., Sani, S. F. A., & Bradley, D. A. (2020) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2020.109294 · Cited by 38 · see citing works
Javid, H., Oryani, M. A., Rezagholinejad, N., Hashemzadeh, A., & Karimi‐Shahri, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00281d · Cited by 24 · see citing works
Triggered Drug Release From Hybrid Thermoresponsive Nanoparticles Using Near Infrared Light
de Solorzano, I. O., Prieto, M., Mendoza, G., et al. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0270 · Cited by 18 · see citing works
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Li, K., Chen, W., Ma, L., Yan, L., & Wang, B. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117264 · Cited by 18 · see citing works
Wang, X., Niu, X., Zhang, X., Zhang, Z., Gao, X., Wang, W., & Yuan, Z. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00515d · Cited by 17 · see citing works
Poly(lactic- co -glycolic acid) encapsulated platinum nanoparticles for cancer treatment
Ruiz, A. L., Arribas, E. V., & McEnnis, K. (2022) · Materials Advances · doi:10.1039/d1ma01155c · Cited by 17 · see citing works
Chuang, Y.-C., Hsia, Y., Chu, C.-H., Lin, L.-J., Sivasubramanian, M., & Lo, L. (2019) · Biomaterials Science · doi:10.1039/c9bm00897g · Cited by 14 · see citing works
Gold Nanostructures as Cancer Theranostic Probe: Promises and Hurdles
Navyatha, B., & Nara, S. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0170 · Cited by 13 · see citing works
Tarantino, S., Bianco, A., Cascione, M., Carlà, A., Fiamà, L., Di Corato, R., Giotta, L., Pellegrino, P., Caricato, A. P., Rinaldi, R., et al. (2025) · Discover Nano · doi:10.1186/s11671-025-04186-x · Cited by 10 · see citing works
“Aditi et al. [19] investigated the radiosensitization effects of hollow AuNPs (50 nm diameter and 35 nm shell thickness) on 4 groups of mice bearing triple-negative breast cancer (TNBC) MDA-MB-231 xenografts.”
Golden era of radiosensitizers
Čížková, J., Dolezal, O. J., Buchta, V., Pospichal, J., Blanař, V., Šinkorová, Z., & Lierová, A. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1450776 · Cited by 6 · see citing works
Measurement of photoelectron generation in a gold coated glass slide
Almugren, K. S., Sani, S. F. A., Uguru, E. H., et al. (2020) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2020.108913 · Cited by 5 · see citing works
Varzandeh, M., Karbasi, M., Labbaf, S., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00096c · Cited by 4 · see citing works
Massard, C., Dubois, C., Raspal, V., Daumar, P., Sibaud, Y., Mounetou, E., Bamdad, M., & Awitor, K. O. (2017) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2018.91002 · Cited by 4 · see citing works
“Gold nanocomposites can also act as radiosensitizer [16] [17] [18] [19] [20] in order to avoid collateral damages induced by the use of radiotherapy.”
BackgroundLunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2 · see citing works
“[15,20,27,28,30,33,34,36,50,63].”
InfluentialNanoradiosensitzers: Preparation, Characterization and Their Performance
Anwar, H., Abbas, B., Khalid, M., Yunas, K., Nosrati, H., Danafar, H., & Sharma, S. K. (2022) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-031-04071-9_4
Dubois, C. (2018) · doi:10.70675/b6bf4c88z2782z442eza7fbz5facbc90936e
Tovar, S., Velasco, B., Cambón, A., et al. (2026) · Journal of Nanoparticle Research · doi:10.1007/s11051-026-06779-8
“Nanocomposites based on gold nanoparticles (AuNPs), for example, have shown strong potential for bio-medical applications, including sensors [9], imaging contrast agents [10], and drug delivery platforms [11], among others.”
- Authors
- Mulgaonkar, A., Moeendarbari, S., Silvers, W., Hassan, G., Sun, X., Hao, Y., & Mao, W.
- Venue
- Journal of Biomedical Nanotechnology
- Publisher
- American Scientific Publishers
- Published
- 2017-05-01
- Volume
- 13
- Issue
- 5
- Pages
- 566-574
- ISSN
- 1550-7033 (ISSN-L)
- OpenAlex
- W2617867020
- Cited by
- 20
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biomedical Nanotechnology (publishedVersion)
- Funders
- University of Texas at Arlington
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- hollow gold nanoparticles, radiosensitizers, radiotherapy, breast cancer, in vivo drug delivery, gold nanoshells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review